NDC 0066-0275-17 - Psorcon E
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0066-0275
- Requested NDC
- 0066-0275-17
- Package NDCs from labels
- 0066-0275-17, 0066-0275-31, 0066-0275-60
- Manufacturer
- Dermik Laboratories, Inc.
- Effective date
- 2006-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PSORCON ® E Emollient Ointment (diflorasone diacetate ointment) 0.05% | Dermik Laboratories, Inc. | 2006-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| diflorasone diacetate | ACTIVE INGREDIENT | 7W2J09SCWX | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 | |
| diflorasone | ACTIVE MOIETY | T2DHJ9645W | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 | |
| lanolin alcohol | INACTIVE INGREDIENT | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 | ||
| polyoxypropylene 15-stearyl ether | INACTIVE INGREDIENT | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 | ||
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 | |
| white petrolatum | INACTIVE INGREDIENT | PSORCON E (DIFLORASONE DIACETATE) OINTMENT [DERMIK LABORATORIES, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| E27130C8-9310-0C80-7EBE-3D3CC9A409B5 | F1B1B77A-9F59-4130-9716-08C835935F37 | 2006-02-06 | Adverse reactions | E27130C8-9310-0C80-7EBE-3D3CC9A409B5 F1B1B77A-9F59-4130-9716-08C835935F37 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.